-
1
-
-
80053168788
-
Rethinking ovarian cancer: recommendations for improving outcomes
-
Vaughan S, Coward JI, Bast RC Jr, Berchuck A, Berek JS, et al. (2011) Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer 11: 719-725.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 719-725
-
-
Vaughan, S.1
Coward, J.I.2
Bast Jr., R.C.3
Berchuck, A.4
Berek, J.S.5
-
2
-
-
84859219044
-
Inflammation and ovarian cancer
-
Maccio A, Madeddu C, (2012) Inflammation and ovarian cancer. Cytokine 58: 133-147.
-
(2012)
Cytokine
, vol.58
, pp. 133-147
-
-
Maccio, A.1
Madeddu, C.2
-
3
-
-
80052855899
-
Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
-
Coward J, Kulbe H, Chakravarty P, Leader D, Vassileva V, et al. (2011) Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer. Clin Cancer Res 17: 6083-6096.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 6083-6096
-
-
Coward, J.1
Kulbe, H.2
Chakravarty, P.3
Leader, D.4
Vassileva, V.5
-
5
-
-
84875995133
-
Bioactive interleukin-6 levels in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer
-
Gastl G, Plante M, (2001) Bioactive interleukin-6 levels in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Methods Mol Med 39: 121-123.
-
(2001)
Methods Mol Med
, vol.39
, pp. 121-123
-
-
Gastl, G.1
Plante, M.2
-
6
-
-
84867499521
-
Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
-
Dijkgraaf EM, Welters MJ, Nortier JW, van der Burg SH, Kroep JR, (2012) Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer. Curr Pharm Des 18: 3816-3827.
-
(2012)
Curr Pharm Des
, vol.18
, pp. 3816-3827
-
-
Dijkgraaf, E.M.1
Welters, M.J.2
Nortier, J.W.3
van der Burg, S.H.4
Kroep, J.R.5
-
7
-
-
84862304990
-
Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells
-
Wang Y, Li L, Guo X, Jin X, Sun W, et al. (2012) Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells. Cytokine 59: 228-236.
-
(2012)
Cytokine
, vol.59
, pp. 228-236
-
-
Wang, Y.1
Li, L.2
Guo, X.3
Jin, X.4
Sun, W.5
-
8
-
-
77953611991
-
Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
-
Wang Y, Niu XL, Qu Y, Wu J, Zhu YQ, et al. (2010) Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Cancer Lett 295: 110-123.
-
(2010)
Cancer Lett
, vol.295
, pp. 110-123
-
-
Wang, Y.1
Niu, X.L.2
Qu, Y.3
Wu, J.4
Zhu, Y.Q.5
-
9
-
-
78751549236
-
IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer
-
Lo CW, Chen MW, Hsiao M, Wang S, Chen CA, et al. (2011) IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer. Cancer Res 71: 424-434.
-
(2011)
Cancer Res
, vol.71
, pp. 424-434
-
-
Lo, C.W.1
Chen, M.W.2
Hsiao, M.3
Wang, S.4
Chen, C.A.5
-
10
-
-
77449086394
-
Interleukin-6 and leptin as markers of energy metabolic changes in advanced ovarian cancer patients
-
Maccio A, Madeddu C, Massa D, Astara G, Farci D, et al. (2008) Interleukin-6 and leptin as markers of energy metabolic changes in advanced ovarian cancer patients. J Cell Mol Med.
-
(2008)
J Cell Mol Med
-
-
Maccio, A.1
Madeddu, C.2
Massa, D.3
Astara, G.4
Farci, D.5
-
11
-
-
0035164602
-
The soluble interleukin 6 receptor: mechanisms of production and implications in disease
-
Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM, (2001) The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 15: 43-58.
-
(2001)
FASEB J
, vol.15
, pp. 43-58
-
-
Jones, S.A.1
Horiuchi, S.2
Topley, N.3
Yamamoto, N.4
Fuller, G.M.5
-
12
-
-
85185194467
-
Inhibition of the IL-6 signaling pathway: A strategy to combat chronic inflammatory diseases and cancer
-
Ataie-Kachoie P, Pourgholami MH, Morris DL (2012) Inhibition of the IL-6 signaling pathway: A strategy to combat chronic inflammatory diseases and cancer. Cytokine Growth Factor Rev.
-
(2012)
Cytokine Growth Factor Rev
-
-
Ataie-Kachoie, P.1
Pourgholami, M.H.2
Morris, D.L.3
-
13
-
-
77956824007
-
Minocycline in the treatment of acne: latest findings
-
Maffeis L, Veraldi S, (2010) Minocycline in the treatment of acne: latest findings. G Ital Dermatol Venereol 145: 425-429.
-
(2010)
G Ital Dermatol Venereol
, vol.145
, pp. 425-429
-
-
Maffeis, L.1
Veraldi, S.2
-
14
-
-
0034820120
-
Minocycline as a therapeutic option in bullous pemphigoid
-
Loo WJ, Kirtschig G, Wojnarowska F, (2001) Minocycline as a therapeutic option in bullous pemphigoid. Clin Exp Dermatol 26: 376-379.
-
(2001)
Clin Exp Dermatol
, vol.26
, pp. 376-379
-
-
Loo, W.J.1
Kirtschig, G.2
Wojnarowska, F.3
-
15
-
-
80054114703
-
Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects
-
Smith CJ, Sayles H, Mikuls TR, Michaud K, (2011) Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects. Arthritis Res Ther 13: R168.
-
(2011)
Arthritis Res Ther
, vol.13
-
-
Smith, C.J.1
Sayles, H.2
Mikuls, T.R.3
Michaud, K.4
-
17
-
-
79958205912
-
Anti-inflammatory properties of doxycycline and minocycline in experimental models: an in vivo and in vitro comparative study
-
Leite LM, Carvalho AG, Ferreira PL, Pessoa IX, Goncalves DO, et al. (2011) Anti-inflammatory properties of doxycycline and minocycline in experimental models: an in vivo and in vitro comparative study. Inflammopharmacology 19: 99-110.
-
(2011)
Inflammopharmacology
, vol.19
, pp. 99-110
-
-
Leite, L.M.1
Carvalho, A.G.2
Ferreira, P.L.3
Pessoa, I.X.4
Goncalves, D.O.5
-
18
-
-
76649110556
-
Minocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat model
-
Cai ZY, Yan Y, Chen R, (2010) Minocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat model. Neurosci Bull 26: 28-36.
-
(2010)
Neurosci Bull
, vol.26
, pp. 28-36
-
-
Cai, Z.Y.1
Yan, Y.2
Chen, R.3
-
19
-
-
79957933723
-
Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice
-
Park CH, Shin TK, Lee HY, Kim SJ, Lee WS, (2011) Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice. Korean J Physiol Pharmacol 15: 115-122.
-
(2011)
Korean J Physiol Pharmacol
, vol.15
, pp. 115-122
-
-
Park, C.H.1
Shin, T.K.2
Lee, H.Y.3
Kim, S.J.4
Lee, W.S.5
-
20
-
-
79953742214
-
Minocycline Inhibition of Monocyte Activation Correlates with Neuronal Protection in SIV NeuroAIDS
-
Campbell JH, Burdo TH, Autissier P, Bombardier JP, Westmoreland SV, et al. (2011) Minocycline Inhibition of Monocyte Activation Correlates with Neuronal Protection in SIV NeuroAIDS. PLoS One 6: e18688.
-
(2011)
PLoS One
, vol.6
-
-
Campbell, J.H.1
Burdo, T.H.2
Autissier, P.3
Bombardier, J.P.4
Westmoreland, S.V.5
-
21
-
-
79960416799
-
Interleukin-6, Produced by Resident Cells of the Central Nervous System and Infiltrating Cells, Contributes to the Development of Seizures Following Viral Infection
-
Libbey JE, Kennett NJ, Wilcox KS, White HS, Fujinami RS (2011) Interleukin-6, Produced by Resident Cells of the Central Nervous System and Infiltrating Cells, Contributes to the Development of Seizures Following Viral Infection. J Virol.
-
(2011)
J Virol
-
-
Libbey, J.E.1
Kennett, N.J.2
Wilcox, K.S.3
White, H.S.4
Fujinami, R.S.5
-
22
-
-
33646534607
-
Suppression of interleukin-6 by minocycline in a rat model of neuropathic pain
-
Zanjani TM, Sabetkasaei M, Mosaffa N, Manaheji H, Labibi F, et al. (2006) Suppression of interleukin-6 by minocycline in a rat model of neuropathic pain. Eur J Pharmacol 538: 66-72.
-
(2006)
Eur J Pharmacol
, vol.538
, pp. 66-72
-
-
Zanjani, T.M.1
Sabetkasaei, M.2
Mosaffa, N.3
Manaheji, H.4
Labibi, F.5
-
23
-
-
0021879340
-
The antitumour effect of doxycycline on a T-cell leukaemia in the rat
-
van den Bogert C, Dontje BH, Kroon AM, (1985) The antitumour effect of doxycycline on a T-cell leukaemia in the rat. Leuk Res 9: 617-623.
-
(1985)
Leuk Res
, vol.9
, pp. 617-623
-
-
van den Bogert, C.1
Dontje, B.H.2
Kroon, A.M.3
-
24
-
-
77953226760
-
Activation of c-Jun N-terminal kinase is essential for mitochondrial membrane potential change and apoptosis induced by doxycycline in melanoma cells
-
Shieh JM, Huang TF, Hung CF, Chou KH, Tsai YJ, et al. (2010) Activation of c-Jun N-terminal kinase is essential for mitochondrial membrane potential change and apoptosis induced by doxycycline in melanoma cells. Br J Pharmacol 160: 1171-1184.
-
(2010)
Br J Pharmacol
, vol.160
, pp. 1171-1184
-
-
Shieh, J.M.1
Huang, T.F.2
Hung, C.F.3
Chou, K.H.4
Tsai, Y.J.5
-
25
-
-
0022640113
-
Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis
-
van den Bogert C, Dontje BH, Holtrop M, Melis TE, Romijn JC, et al. (1986) Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis. Cancer Res 46: 3283-3289.
-
(1986)
Cancer Res
, vol.46
, pp. 3283-3289
-
-
van den Bogert, C.1
Dontje, B.H.2
Holtrop, M.3
Melis, T.E.4
Romijn, J.C.5
-
26
-
-
0035109570
-
Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells
-
Meng Q, Xu J, Goldberg ID, Rosen EM, Greenwald RA, et al. (2000) Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells. Clin Exp Metastasis 18: 139-146.
-
(2000)
Clin Exp Metastasis
, vol.18
, pp. 139-146
-
-
Meng, Q.1
Xu, J.2
Goldberg, I.D.3
Rosen, E.M.4
Greenwald, R.A.5
-
27
-
-
84859623859
-
Minocycline inhibits growth of epithelial ovarian cancer
-
Pourgholami MH, Mekkawy AH, Badar S, Morris DL, (2012) Minocycline inhibits growth of epithelial ovarian cancer. Gynecol Oncol 125: 433-440.
-
(2012)
Gynecol Oncol
, vol.125
, pp. 433-440
-
-
Pourgholami, M.H.1
Mekkawy, A.H.2
Badar, S.3
Morris, D.L.4
-
28
-
-
85185201103
-
Minocycline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways
-
Pourgholami MH, Ataie-Kachoie P, Badar S, Morris DL (2012) Minocycline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways. Gynecol Oncol.
-
(2012)
Gynecol Oncol
-
-
Pourgholami, M.H.1
Ataie-Kachoie, P.2
Badar, S.3
Morris, D.L.4
-
30
-
-
0015906270
-
Pharmacokinetic studies on minocycline in man
-
Macdonald H, Kelly RG, Allen ES, Noble JF, Kanegis LA, (1973) Pharmacokinetic studies on minocycline in man. Clin Pharmacol Ther 14: 852-861.
-
(1973)
Clin Pharmacol Ther
, vol.14
, pp. 852-861
-
-
Macdonald, H.1
Kelly, R.G.2
Allen, E.S.3
Noble, J.F.4
Kanegis, L.A.5
-
31
-
-
2442715084
-
Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis
-
Gordon PH, Moore DH, Gelinas DF, Qualls C, Meister ME, et al. (2004) Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology 62: 1845-1847.
-
(2004)
Neurology
, vol.62
, pp. 1845-1847
-
-
Gordon, P.H.1
Moore, D.H.2
Gelinas, D.F.3
Qualls, C.4
Meister, M.E.5
-
32
-
-
80355123687
-
Gingival fibroblasts display reduced adhesion and spreading on extracellular matrix: a possible basis for scarless tissue repair?
-
Guo F, Carter DE, Mukhopadhyay A, Leask A, (2011) Gingival fibroblasts display reduced adhesion and spreading on extracellular matrix: a possible basis for scarless tissue repair? PLoS One 6: e27097.
-
(2011)
PLoS One
, vol.6
-
-
Guo, F.1
Carter, D.E.2
Mukhopadhyay, A.3
Leask, A.4
-
33
-
-
54449088686
-
Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IkappaB kinase alpha pathway targeting activator protein-1
-
Cahill CM, Rogers JT, (2008) Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IkappaB kinase alpha pathway targeting activator protein-1. J Biol Chem 283: 25900-25912.
-
(2008)
J Biol Chem
, vol.283
, pp. 25900-25912
-
-
Cahill, C.M.1
Rogers, J.T.2
-
34
-
-
84873169131
-
Ovarian epithelial-stromal interactions: role of interleukins 1 and 6
-
Woolery KT, Kruk PA, (2011) Ovarian epithelial-stromal interactions: role of interleukins 1 and 6. Obstet Gynecol Int 2011: 358493.
-
(2011)
Obstet Gynecol Int
, vol.2011
, pp. 358493
-
-
Woolery, K.T.1
Kruk, P.A.2
-
35
-
-
0031668090
-
Effect of estrogens on IL-1beta promoter activity
-
Ruh MF, Bi Y, D'Alonzo R, Bellone CJ, (1998) Effect of estrogens on IL-1beta promoter activity. J Steroid Biochem Mol Biol 66: 203-210.
-
(1998)
J Steroid Biochem Mol Biol
, vol.66
, pp. 203-210
-
-
Ruh, M.F.1
Bi, Y.2
D'Alonzo, R.3
Bellone, C.J.4
-
36
-
-
23744501325
-
Estradiol metabolites are potent mitogenic substances for human ovarian cancer cells
-
Seeger H, Wallwiener D, Kraemer E, Mueck AO, (2005) Estradiol metabolites are potent mitogenic substances for human ovarian cancer cells. Eur J Gynaecol Oncol 26: 383-385.
-
(2005)
Eur J Gynaecol Oncol
, vol.26
, pp. 383-385
-
-
Seeger, H.1
Wallwiener, D.2
Kraemer, E.3
Mueck, A.O.4
-
37
-
-
1642283086
-
4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells
-
Gao N, Nester RA, Sarkar MA, (2004) 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Toxicol Appl Pharmacol 196: 124-135.
-
(2004)
Toxicol Appl Pharmacol
, vol.196
, pp. 124-135
-
-
Gao, N.1
Nester, R.A.2
Sarkar, M.A.3
-
38
-
-
0142212329
-
Regulation of matrix metalloproteinases: an overview
-
Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T, (2003) Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253: 269-285.
-
(2003)
Mol Cell Biochem
, vol.253
, pp. 269-285
-
-
Chakraborti, S.1
Mandal, M.2
Das, S.3
Mandal, A.4
Chakraborti, T.5
-
40
-
-
78649741783
-
gp130 at the nexus of inflammation, autoimmunity, and cancer
-
Silver JS, Hunter CA, (2010) gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol 88: 1145-1156.
-
(2010)
J Leukoc Biol
, vol.88
, pp. 1145-1156
-
-
Silver, J.S.1
Hunter, C.A.2
-
41
-
-
78650356983
-
Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer
-
Guo Y, Nemeth J, O'Brien C, Susa M, Liu X, et al. (2010) Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer. Clin Cancer Res 16: 5759-5769.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 5759-5769
-
-
Guo, Y.1
Nemeth, J.2
O'Brien, C.3
Susa, M.4
Liu, X.5
-
42
-
-
77953091816
-
Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer
-
Dorff TB, Goldman B, Pinski JK, Mack PC, Lara PN Jr, et al. (2010) Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer. Clin Cancer Res 16: 3028-3034.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 3028-3034
-
-
Dorff, T.B.1
Goldman, B.2
Pinski, J.K.3
Mack, P.C.4
Lara Jr., P.N.5
-
43
-
-
33751575658
-
The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis
-
Rosen DG, Mercado-Uribe I, Yang G, Bast RC Jr, Amin HM, et al. (2006) The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer 107: 2730-2740.
-
(2006)
Cancer
, vol.107
, pp. 2730-2740
-
-
Rosen, D.G.1
Mercado-Uribe, I.2
Yang, G.3
Bast Jr., R.C.4
Amin, H.M.5
-
45
-
-
77249098774
-
Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice
-
Musteanu M, Blaas L, Mair M, Schlederer M, Bilban M, et al. (2010) Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice. Gastroenterology 138: 1003-1011 e1001-1005.
-
(2010)
Gastroenterology
, vol.138
, pp. 1001-1011
-
-
Musteanu, M.1
Blaas, L.2
Mair, M.3
Schlederer, M.4
Bilban, M.5
-
46
-
-
84871862427
-
STAT3 negatively regulates thyroid tumorigenesis
-
Couto JP, Daly L, Almeida A, Knauf JA, Fagin JA, et al. (2012) STAT3 negatively regulates thyroid tumorigenesis. Proc Natl Acad Sci U S A 109: E2361-2370.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
-
-
Couto, J.P.1
Daly, L.2
Almeida, A.3
Knauf, J.A.4
Fagin, J.A.5
-
47
-
-
33947308781
-
Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10
-
Torres-Roca JF, DeSilvio M, Mora LB, Khor LY, Hammond E, et al. (2007) Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10. Urology 69: 505-509.
-
(2007)
Urology
, vol.69
, pp. 505-509
-
-
Torres-Roca, J.F.1
DeSilvio, M.2
Mora, L.B.3
Khor, L.Y.4
Hammond, E.5
-
48
-
-
84865023635
-
Cytokine gene expression signature in ovarian clear cell carcinoma
-
Yanaihara N, Anglesio MS, Ochiai K, Hirata Y, Saito M, et al. (2012) Cytokine gene expression signature in ovarian clear cell carcinoma. Int J Oncol 41: 1094-1100.
-
(2012)
Int J Oncol
, vol.41
, pp. 1094-1100
-
-
Yanaihara, N.1
Anglesio, M.S.2
Ochiai, K.3
Hirata, Y.4
Saito, M.5
-
49
-
-
84875991343
-
[Effects of siltuximab on the interleukin-6/Stat3 signaling pathway in ovarian cancer]
-
Guo YQ, Lu P, Duan ZF, Zhang Z, (2010) [Effects of siltuximab on the interleukin-6/Stat3 signaling pathway in ovarian cancer]. Zhonghua Fu Chan Ke Za Zhi 45: 854-859.
-
(2010)
Zhonghua Fu Chan Ke Za Zhi
, vol.45
, pp. 854-859
-
-
Guo, Y.Q.1
Lu, P.2
Duan, Z.F.3
Zhang, Z.4
-
50
-
-
0036554816
-
Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention
-
Buettner R, Mora LB, Jove R, (2002) Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8: 945-954.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 945-954
-
-
Buettner, R.1
Mora, L.B.2
Jove, R.3
-
51
-
-
34548016800
-
STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes
-
Zhang X, Zhang J, Wei H, Tian Z, (2007) STAT3-decoy oligodeoxynucleotide inhibits the growth of human lung cancer via down-regulating its target genes. Oncol Rep 17: 1377-1382.
-
(2007)
Oncol Rep
, vol.17
, pp. 1377-1382
-
-
Zhang, X.1
Zhang, J.2
Wei, H.3
Tian, Z.4
-
52
-
-
31544458469
-
Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells
-
Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, et al. (2006) Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 12: 11-19.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 11-19
-
-
Gritsko, T.1
Williams, A.2
Turkson, J.3
Kaneko, S.4
Bowman, T.5
-
53
-
-
58849152837
-
CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells
-
Duan Z, Ames RY, Ryan M, Hornicek FJ, Mankin H, et al. (2009) CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. Cancer Chemother Pharmacol 63: 681-689.
-
(2009)
Cancer Chemother Pharmacol
, vol.63
, pp. 681-689
-
-
Duan, Z.1
Ames, R.Y.2
Ryan, M.3
Hornicek, F.J.4
Mankin, H.5
-
54
-
-
77951249948
-
[Relationship of IL-6 and IL-8 secretion in epithelial ovarian cancer cell lines with their sensitivity to tamoxifen as well as MAPK, Akt and estrogen receptor phosphorylation]
-
Wang Y, Guo XQ, Niu XL, Wu J, Zhu YQ, et al. (2010) [Relationship of IL-6 and IL-8 secretion in epithelial ovarian cancer cell lines with their sensitivity to tamoxifen as well as MAPK, Akt and estrogen receptor phosphorylation]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 26: 21-24.
-
(2010)
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
, vol.26
, pp. 21-24
-
-
Wang, Y.1
Guo, X.Q.2
Niu, X.L.3
Wu, J.4
Zhu, Y.Q.5
-
55
-
-
25444488221
-
Modeling resistance to pathway-targeted therapy in ovarian cancer
-
Xing D, Orsulic S, (2005) Modeling resistance to pathway-targeted therapy in ovarian cancer. Cell Cycle 4: 1004-1006.
-
(2005)
Cell Cycle
, vol.4
, pp. 1004-1006
-
-
Xing, D.1
Orsulic, S.2
-
56
-
-
80052211582
-
Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding
-
Kleiman LB, Maiwald T, Conzelmann H, Lauffenburger DA, Sorger PK, (2011) Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding. Mol Cell 43: 723-737.
-
(2011)
Mol Cell
, vol.43
, pp. 723-737
-
-
Kleiman, L.B.1
Maiwald, T.2
Conzelmann, H.3
Lauffenburger, D.A.4
Sorger, P.K.5
-
57
-
-
37549039091
-
IL-1beta-stimulated activation of ERK1/2 and p38alpha MAPK mediates the transcriptional up-regulation of IL-6, IL-8 and GRO-alpha in HeLa cells
-
Yang HT, Cohen P, Rousseau S, (2008) IL-1beta-stimulated activation of ERK1/2 and p38alpha MAPK mediates the transcriptional up-regulation of IL-6, IL-8 and GRO-alpha in HeLa cells. Cell Signal 20: 375-380.
-
(2008)
Cell Signal
, vol.20
, pp. 375-380
-
-
Yang, H.T.1
Cohen, P.2
Rousseau, S.3
-
58
-
-
33746092509
-
Touched and moved by STAT3
-
Gao SP, Bromberg JF, (2006) Touched and moved by STAT3. Sci STKE 2006: pe30.
-
(2006)
Sci STKE
, vol.2006
-
-
Gao, S.P.1
Bromberg, J.F.2
-
59
-
-
4644372401
-
Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity
-
Bar JK, Grelewski P, Popiela A, Noga L, Rabczynski J, (2004) Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity. Gynecol Oncol 95: 23-31.
-
(2004)
Gynecol Oncol
, vol.95
, pp. 23-31
-
-
Bar, J.K.1
Grelewski, P.2
Popiela, A.3
Noga, L.4
Rabczynski, J.5
-
60
-
-
67651006538
-
Tocilizumab inhibits interleukin-6-mediated matrix metalloproteinase-2 and -9 secretions from human amnion cells in preterm premature rupture of membranes
-
Mano Y, Shibata K, Sumigama S, Hayakawa H, Ino K, et al. (2009) Tocilizumab inhibits interleukin-6-mediated matrix metalloproteinase-2 and-9 secretions from human amnion cells in preterm premature rupture of membranes. Gynecol Obstet Invest 68: 145-153.
-
(2009)
Gynecol Obstet Invest
, vol.68
, pp. 145-153
-
-
Mano, Y.1
Shibata, K.2
Sumigama, S.3
Hayakawa, H.4
Ino, K.5
-
61
-
-
79551663713
-
Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cells
-
Hsu CP, Chen YL, Huang CC, Chou CC, Liu CL, et al. (2011) Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cells. Eur J Clin Invest 41: 277-284.
-
(2011)
Eur J Clin Invest
, vol.41
, pp. 277-284
-
-
Hsu, C.P.1
Chen, Y.L.2
Huang, C.C.3
Chou, C.C.4
Liu, C.L.5
-
62
-
-
84864352003
-
Minocycline inhibits alkali burn-induced corneal neovascularization in mice
-
Xiao O, Xie ZL, Lin BW, Yin XF, Pi RB, et al. (2012) Minocycline inhibits alkali burn-induced corneal neovascularization in mice. PLoS One 7: e41858.
-
(2012)
PLoS One
, vol.7
-
-
Xiao, O.1
Xie, Z.L.2
Lin, B.W.3
Yin, X.F.4
Pi, R.B.5
-
63
-
-
77953473424
-
Attenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic rats
-
Bhatt LK, Addepalli V, (2010) Attenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic rats. Am J Transl Res 2: 181-189.
-
(2010)
Am J Transl Res
, vol.2
, pp. 181-189
-
-
Bhatt, L.K.1
Addepalli, V.2
|